Diabetes: Progress toward stem cell therapies, a Live Google Hangout

California's Stem Cell Agency (CIRM) hosted a live Google Hangout about recent progress in stem cell based strategies for diabetes therapies.
The speakers included:
Francisco Prieto, MD - CIRM's diabetes patient advocate governing board member. Dr. Prieto is a practicing physician and researcher who has been active in diabetes care, patient and professional education and exercise promotion throughout his career.
Chris Stiehl, a patient advocate for diabetes who has been living with type 1 for 50 years and a former Board member for the Juvenile Diabetes Research Foundation
Kevin D'Amour, PhD Chief Scientific Officer and Howard Foyt, MD, PhD, Chief Medical Officer, ViaCyte, Inc. 
Viacyte, a CIRM-funded, San Diego-based company has developed a device that is implanted under the skin and that secretes insulin and other hormones to keep blood glucose levels under control. The device contains insulin-producing pancreatic beta cells derived from human embryonic stem cells. The product is scheduled to enter clinical this year.

Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog